other Serialization requirements around the world:
a quick overview
Discover the Global Serialization Landscape for Pharmaceuticals
Take a look at our global serialization landscape for pharmaceutical products to have an overview of the state of the different laws and regulations pertaining to drug serialization and aggregation around the world as well as the main milestones.
To make the pharmaceutical supply chain safer and ensure patients get the medicines they need, the Russian Ministry of Health intends to put in place serialization and aggregation requirements for drugs.
The Saudi Food and Drug Authority (SFDA) has published the latest version of the Saudi Drug Code (SDC) in November 2016. Its aim is to fight against counterfeit pharmaceuticals and to make Saudi Arabia’s drug supply chain safer and more efficient.
On December 28, 2016, after lengthy discussions and a temporary suspension of already active legislation related to pharmaceutical serialization, the Brazilian President signed the law 13.410, thus amending the ones dating back to 2009 and 2013.
Recently, Chinese authorities issues new guidance documents claryfing drug traceability requirements to come into force by 2022.
To ensure a safe and efficient pharmaceutical supply chain, the Drug Regulatory Authority of Pakistan (DRAP) is planning to implement serialization and track&trace measures. All drugs will have to be uniquely identified and serialized in the future.
The EU Medical Devices Regulation (MDR) has introduced a device traceability system based on Unique Device Identification or in short UDI. Official date of application of the EU MDR is 26 May 2020.